Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501041PMID: 30000100
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 42924-53-8
Drug Levels and Effects
Summary of Use during Lactation
Because no information is available on the use of nabumetone during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Acetaminophen, Flurbiprofen, Ibuprofen, Indomethacin, Naproxen, Piroxicam
Substance Identification
Substance Name
Nabumetone
CAS Registry Number
42924-53-8
Drug Class
Breast Feeding
Lactation
Milk, Human
Analgesic Agents
Anti-inflammatory Agents, Nonsteroidal
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.[Xenobiotica. 2020]A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.Matsumoto K, Hasegawa T, Ohara K, Takei C, Kamei T, Koyanagi J, Takahashi T, Akimoto M. Xenobiotica. 2020 Jul; 50(7):783-792. Epub 2019 Dec 27.
- Review Sulindac.[Drugs and Lactation Database (...]Review Sulindac.. Drugs and Lactation Database (LactMed®). 2006
- Review Torsemide.[Drugs and Lactation Database (...]Review Torsemide.. Drugs and Lactation Database (LactMed®). 2006
- Review Meclofenamate.[Drugs and Lactation Database (...]Review Meclofenamate.. Drugs and Lactation Database (LactMed®). 2006
- Review Piroxicam.[Drugs and Lactation Database (...]Review Piroxicam.. Drugs and Lactation Database (LactMed®). 2006
- Nabumetone - Drugs and Lactation Database (LactMed®)Nabumetone - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...